19-norpregnane steroids as neurochemical initiators of change in human hypothalamic function
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 5, 2001
Grant Date -
N/A
app pub date -
Aug 11, 1998
filing date -
Aug 4, 1994
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Several 19-nor-pregnanes are provided which have the capacity to neurochemically alter the hypothalamic function in an individual through nasal administration. These pharmaceutically active compounds can be administered by themselves or in the form of a pharmaceutical composition containing one or more pharmaceutically acceptable carriers to produce the desired effect.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully